Natco Pharma received seven observations from the US FDA following an inspection at its Kothur facility in Hyderabad. The company plans to address them. Natco Pharma has received seven observations from the US Food and Drug Administration following an inspection of its formulations manufacturing facility in Kothur, Hyderabad.The inspection was conducted between November 12 and November 20, 2026.